Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Association between 9p21 genomic markers and heart disease: a meta-analysis.

Palomaki GE, Melillo S, Bradley LA.

JAMA. 2010 Feb 17;303(7):648-56. doi: 10.1001/jama.2010.118.

PMID:
20159873
2.

Association between 9p21.3 genomic markers and coronary artery disease in East Asians: a meta-analysis involving 9,813 cases and 10,710 controls.

Guo J, Li W, Wu Z, Cheng X, Wang Y, Chen T.

Mol Biol Rep. 2013 Jan;40(1):337-43. doi: 10.1007/s11033-012-2066-1. Epub 2012 Oct 20.

PMID:
23086272
3.

Association between 1p13.3 genomic markers and coronary artery disease: a meta-analysis involving patients and controls.

Guo J, Luo YX, Tao LX, Guo XH.

Genet Mol Res. 2015 Aug 7;14(3):9092-102. doi: 10.4238/2015.August.7.18.

4.

Association of chromosome 9p21 genetic variants with risk of coronary heart disease in the East Asian population: a meta-analysis.

Dong L, Wang H, Wang DW, Ding H.

Ann Hum Genet. 2013 May;77(3):183-90. doi: 10.1111/ahg.12010. Epub 2013 Jan 24.

5.

Association between 9p21 genomic markers and ischemic stroke risk: evidence based on 21 studies.

Ni X, Zhang J.

PLoS One. 2014 Mar 13;9(3):e90255. doi: 10.1371/journal.pone.0090255. eCollection 2014 Mar 13.

6.

Genetic variants in loci 1p13 and 9p21 and fatal coronary heart disease in a Norwegian case-cohort study.

Jansen MD, Knudsen GP, Myhre R, Høiseth G, Mørland J, Næss Ø, Tambs K, Magnus P.

Mol Biol Rep. 2014 May;41(5):2733-43. doi: 10.1007/s11033-014-3096-7. Epub 2014 Apr 13.

PMID:
24728607
7.

Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease.

Virani SS, Brautbar A, Lee VV, MacArthur E, Morrison AC, Grove ML, Nambi V, Frazier L, Wilson JM, Willerson JT, Boerwinkle E, Ballantyne CM.

Circ J. 2012;76(4):950-6. Epub 2012 Feb 9.

8.

Differential effects of chromosome 9p21 variation on subphenotypes of intracranial aneurysm: site distribution.

Nakaoka H, Takahashi T, Akiyama K, Cui T, Tajima A, Krischek B, Kasuya H, Hata A, Inoue I.

Stroke. 2010 Aug;41(8):1593-8. doi: 10.1161/STROKEAHA.110.586529. Epub 2010 Jul 1.

9.

Meta-analysis of genetic association of chromosome 9p21 with early-onset coronary artery disease.

Zhou LT, Qin L, Zheng DC, Song ZK, Ye L.

Gene. 2012 Dec 1;510(2):185-8. doi: 10.1016/j.gene.2012.09.003. Epub 2012 Sep 10.

PMID:
22975211
10.

Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study.

Assimes TL, Knowles JW, Basu A, Iribarren C, Southwick A, Tang H, Absher D, Li J, Fair JM, Rubin GD, Sidney S, Fortmann SP, Go AS, Hlatky MA, Myers RM, Risch N, Quertermous T.

Hum Mol Genet. 2008 Aug 1;17(15):2320-8. doi: 10.1093/hmg/ddn132. Epub 2008 Apr 28.

11.

A common variant on chromosome 9p21 affects the risk of early-onset coronary artery disease.

Chen Z, Qian Q, Ma G, Wang J, Zhang X, Feng Y, Shen C, Yao Y.

Mol Biol Rep. 2009 May;36(5):889-93. doi: 10.1007/s11033-008-9259-7. Epub 2008 May 6.

PMID:
18459066
12.

Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke.

Gschwendtner A, Bevan S, Cole JW, Plourde A, Matarin M, Ross-Adams H, Meitinger T, Wichmann E, Mitchell BD, Furie K, Slowik A, Rich SS, Syme PD, MacLeod MJ, Meschia JF, Rosand J, Kittner SJ, Markus HS, Müller-Myhsok B, Dichgans M; International Stroke Genetics Consortium..

Ann Neurol. 2009 May;65(5):531-9. doi: 10.1002/ana.21590.

13.

Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.

Lusk CM, Dyson G, Clark AG, Ballantyne CM, Frikke-Schmidt R, Tybjærg-Hansen A, Boerwinkle E, Sing CF.

Hum Genet. 2014 Sep;133(9):1105-16. doi: 10.1007/s00439-014-1451-3. Epub 2014 Jun 3.

14.

The 9p21 susceptibility locus for coronary artery disease and the severity of coronary atherosclerosis.

Chen SN, Ballantyne CM, Gotto AM Jr, Marian AJ.

BMC Cardiovasc Disord. 2009 Jan 27;9:3. doi: 10.1186/1471-2261-9-3.

15.

Polymorphisms on chromosome 9p21 confer a risk for acute coronary syndrome in a Chinese Han population.

Zeng Q, Yuan Y, Wang S, Sun J, Zhang T, Qi M.

Can J Cardiol. 2013 Aug;29(8):940-4. doi: 10.1016/j.cjca.2012.11.028. Epub 2013 Mar 1.

PMID:
23454037
16.

Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21.

Matarin M, Brown WM, Singleton A, Hardy JA, Meschia JF; ISGS investigators..

Stroke. 2008 May;39(5):1586-9. doi: 10.1161/STROKEAHA.107.502963. Epub 2008 Mar 13.

17.

Recommendations from the EGAPP Working Group: genomic profiling to assess cardiovascular risk to improve cardiovascular health.

Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group..

Genet Med. 2010 Dec;12(12):839-43. doi: 10.1097/GIM.0b013e3181f872c0.

PMID:
21042222
18.

The effect of chromosome 9p21 variants on cardiovascular disease may be modified by dietary intake: evidence from a case/control and a prospective study.

Do R, Xie C, Zhang X, Männistö S, Harald K, Islam S, Bailey SD, Rangarajan S, McQueen MJ, Diaz R, Lisheng L, Wang X, Silander K, Peltonen L, Yusuf S, Salomaa V, Engert JC, Anand SS; INTERHEART investigators..

PLoS Med. 2011 Oct;8(10):e1001106. doi: 10.1371/journal.pmed.1001106. Epub 2011 Oct 11.

19.

Influence of 9p21.3 genetic variants on clinical and angiographic outcomes in early-onset myocardial infarction.

Ardissino D, Berzuini C, Merlini PA, Mannuccio Mannucci P, Surti A, Burtt N, Voight B, Tubaro M, Peyvandi F, Spreafico M, Celli P, Lina D, Notarangelo MF, Ferrario M, Fetiveau R, Casari G, Galli M, Ribichini F, Rossi ML, Bernardi F, Marziliano N, Zonzin P, Mauri F, Piazza A, Foco L, Bernardinelli L, Altshuler D, Kathiresan S; Italian Atherosclerosis, Thrombosis and Vascular Biology Investigators..

J Am Coll Cardiol. 2011 Jul 19;58(4):426-34. doi: 10.1016/j.jacc.2010.11.075.

20.

Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifying therapy in the Atherosclerosis Risk in Communities study.

Brautbar A, Ballantyne CM, Lawson K, Nambi V, Chambless L, Folsom AR, Willerson JT, Boerwinkle E.

Circ Cardiovasc Genet. 2009 Jun;2(3):279-85. doi: 10.1161/CIRCGENETICS.108.817338. Epub 2009 Apr 21.

Supplemental Content

Support Center